Literature DB >> 7641412

The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey.

M P Vanderpump1, W M Tunbridge, J M French, D Appleton, D Bates, F Clark, J Grimley Evans, D M Hasan, H Rodgers, F Tunbridge.   

Abstract

BACKGROUND AND
OBJECTIVE: The original Whickham Survey documented the prevalence of thyroid disorders in a randomly selected sample of 2779 adults which matched the population of Great Britain in age, sex and social class. The aim of the twenty-year follow-up survey was to determine the incidence and natural history of thyroid disease in this cohort. DESIGN, PATIENTS AND MEASUREMENTS: Subjects were traced at follow-up via the Electoral Register, General Practice registers, Gateshead Family Health Services Authority register and Office of Population Censuses and Surveys. Eight hundred and twenty-five subjects (30% of the sample) had died and, in addition to death certificates, two-thirds had information from either hospital/General Practitioner notes or post-mortem reports to document morbidity prior to death. Of the 1877 known survivors, 96% participated in the follow-up study and 91% were tested for clinical, biochemical and immunological evidence of thyroid dysfunction.
RESULTS: Outcomes in terms of morbidity and mortality were determined for over 97% of the original sample. The mean incidence (with 95% confidence intervals) of spontaneous hypothyroidism in women was 3.5/1000 survivors/year (2.8-4.5) rising to 4.1/1000 survivors/year (3.3-5.0) for all causes of hypothyroidism and in men was 0.6/1000 survivors/year (0.3-1.2). The mean incidence of hyperthyroidism in women was 0.8/1000 survivors/year (0.5-1.4) and was negligible in men. Similar incidence rates were calculated for the deceased subjects. An estimate of the probability of the development of hypothyroidism and hyperthyroidism at a particular time, i.e. the hazard rate, showed an increase with age in hypothyroidism but no age relation in hyperthyroidism. The frequency of goitre decreased with age with 10% of women and 2% of men having a goitre at follow-up, as compared to 23% and 5% in the same subjects respectively at the first survey. The presence of a goitre at either survey was not associated with any clinical or biochemical evidence of thyroid dysfunction. In women, an association was found between the development of a goitre and thyroid-antibody status at follow-up, but not initially. The risk of having developed hypothyroidism at follow-up was examined with respect to risk factors identified at first survey. The odds ratios (with 95% confidence intervals) of developing hypothyroidism with (a) raised serum TSH alone were 8 (3-20) for women and 44 (19-104) for men; (b) positive anti-thyroid antibodies alone were 8 (5-15) for women and 25 (10-63) for men; (c) both raised serum TSH and positive anti-thyroid antibodies were 38 (22-65) for women and 173 (81-370) for men. A logit model indicated that increasing values of serum TSH above 2mU/l at first survey increased the probability of developing hypothyroidism which was further increased in the presence of anti-thyroid antibodies. Neither a positive family history of any form of thyroid disease nor parity of women at first survey was associated with increased risk of developing hypothyroidism. Fasting cholesterol and triglyceride levels at first survey when corrected for age showed no association with the development of hypothyroidism in women.
CONCLUSIONS: This historical cohort study has provided incidence data for thyroid disease over a twenty-year period for a representative cross-sectional sample of the population, and has allowed the determination of the importance of prognostic risk factors for thyroid disease identified twenty years earlier.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7641412     DOI: 10.1111/j.1365-2265.1995.tb01894.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  434 in total

1.  The prevalence and incidence of medical conditions in healthy pharmaceutical company employees who volunteer to participate in medical research.

Authors:  S D Singh; A J Williams
Journal:  Br J Clin Pharmacol       Date:  1999-07       Impact factor: 4.335

Review 2.  Thyroid function tests-time for a reassessment.

Authors:  D S O'Reilly
Journal:  BMJ       Date:  2000-05-13

3.  Autoantibodies as predictors of disease.

Authors:  D Leslie; P Lipsky; A L Notkins
Journal:  J Clin Invest       Date:  2001-11       Impact factor: 14.808

Review 4.  Thyroid disorders--an update.

Authors:  J H Lazarus; K Obuobie
Journal:  Postgrad Med J       Date:  2000-09       Impact factor: 2.401

Review 5.  Management of the unexpected result: compensated hypothyroidism.

Authors:  R Benediktsson; A D Toft
Journal:  Postgrad Med J       Date:  1998-12       Impact factor: 2.401

6.  Targeted thyroid testing in acute illness: achieving success through audit.

Authors:  M A Adlan; V Neel; S S Lakra; L N R Bondugulapati; L D K E Premawardhana
Journal:  J Endocrinol Invest       Date:  2011-01-26       Impact factor: 4.256

7.  TPOAb and Thyroid Function Are Not Associated with Breast Cancer Outcome: Evidence from a Large-Scale Study Using Data from the Taxotere as Adjuvant Chemotherapy Trial (TACT, CRUK01/001).

Authors:  Ilaria Muller; Lucy S Kilburn; Peter N Taylor; Peter J Barrett-Lee; Judith M Bliss; Paul Ellis; Marian E Ludgate; Colin M Dayan
Journal:  Eur Thyroid J       Date:  2017-04-04

Review 8.  Hypothyroidism and dyslipidemia: modern concepts and approaches.

Authors:  Elizabeth N Pearce
Journal:  Curr Cardiol Rep       Date:  2004-11       Impact factor: 2.931

9.  How good is the levothyroxine replacement in primary hypothyroidism patients in Brazil? Data of a multicentre study.

Authors:  F Vaisman; C Medina Coeli; L S Ward; H Graf; G Carvalho; R Montenegro; M Vaisman
Journal:  J Endocrinol Invest       Date:  2013-01-14       Impact factor: 4.256

10.  Common and unique susceptibility loci in Graves and Hashimoto diseases: results of whole-genome screening in a data set of 102 multiplex families.

Authors:  Yaron Tomer; Yoshiyuki Ban; Erlinda Concepcion; Giuseppe Barbesino; Ronald Villanueva; David A Greenberg; Terry F Davies
Journal:  Am J Hum Genet       Date:  2003-09-12       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.